Furthermore, we did not utilize "post hoc reconstructions" of X-Y plots; thus phase lag in recording flow-box volume was also eliminated as a possible source of error (see METHODS) . Importantly, the contention that sRaw by RWBP was artificially low in our study is contrary to the evidence presented (i.e., invasive sRaw-forced oscillation technique ϭ 0.095 cm ‫ء‬ s, which was 1/5th of sRaw-RWBP vs. 1/19th of sRaw-DCP in our study; 4/5th of Raw is due to upper airways, so sRaw-RWBP was within 5% predicted sRaw). Until the accuracy and reproducibility of sRaw using dual chamber systems are also rigorously evaluated in mice, the apparent inconsistencies at baseline and after methacholine (6) will continue to create problems with interpretation, or, at the least, ongoing technical challenges for users. Because the baseline measurements of sRaw are valuable for longitudinal evaluation, as recently documented by Agrawal et al. (1), and dictate the slope (anchor point) of the dose-response curve, this discussion is more than academic. Concerning the diversion of airflow through the mouth, this is an innovative way to avoid nasal contributions to sRaw. However, the contributions of oropharyngeal resistance and air volume to sRaw, and the source of erratic breathing they observed (1) will need to be better characterized. It is gratifying that A. Agrawal and A. Ram have initiated this dialogue. With the increasing use of mice to model aspects of human asthma (13), we need to continue working to refine the methods of conscious measurements until the benefits clearly outweigh the controversies.
